Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jan 2024 |
---|---|---|---|---|
Total reported revenue | 45.1B | 34.3B | 33.6B | 37.1B |
Cost of revenue | 34.6B | 26.4B | 25.9B | 28.6B |
Gross profit | 10.6B | 7.9B | 7.7B | 8.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 271M | 205M | 203M | 220M |
Other operating expenses | 7.9B | 6.0B | 5.9B | 6.3B |
Operating income | 1.3B | 912M | 828M | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 199M | 156M | 86M | 100M |
Other income expense | -20M | -20M | 62M | -160M |
Pretax income | 1.1B | 736M | 804M | 934M |
Tax provision | 235M | 102M | 187M | 195M |
Net income | 868M | 634M | 617M | 739M |
Basic EPS | 1.3 | — | 0.9 | 1.0 |
Diluted EPS | 1.3 | — | 0.8 | 1.0 |
Basic average shares | 660M | — | 723M | 719M |
Diluted average shares | 664M | — | 728M | 725M |
EBITDA | 2.6B | 1.8B | 1.7B | 2.1B |
Net income from continuing op. | 868M | 634M | 617M | 739M |
Minority interests | -2M | 0 | 1M | -3M |
Preferred stock dividends | — | — | — | — |